MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling (Q24304423)

GOA release 2020-03-11

Chong Sun

9

0 references

Ultan McDermott

Ultan McDermott

6

0 references

Sjaak Neefjes

Jacques Neefjes

14

0 references

René Bernards

René Bernards

21

0 references

Peter Ten Dijke

16

Peter Ten Dijke

0 references

author name string

Sidong Huang

1

0 references

Michael Hölzel

2

0 references

Theo Knijnenburg

3

0 references

Andreas Schlicker

4

0 references

Paul Roepman

5

0 references

Mathew Garnett

7

0 references

Wipawadee Grernrum

8

0 references

Anirudh Prahallad

10

0 references

Floris H Groenendijk

11

0 references

Lorenza Mittempergher

12

0 references

Wouter Nijkamp

13

0 references

Ramon Salazar

15

0 references

Hidetaka Uramoto

17

0 references

Fumihiro Tanaka

18

0 references

Roderick L Beijersbergen

19

0 references

Lodewyk F A Wessels

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

20

0 references

language of work or name

English

0 references

publication date

21 November 2012

0 references

published in

Cell

0 references

volume

151

0 references

issue

5

0 references

page(s)

937-50

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

The protein kinase complement of the human genome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Epithelial-mesenchymal transitions in development and disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Systematic identification of genomic markers of drug sensitivity in cancer cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Non-Smad pathways in TGF-beta signaling

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

EMT is the dominant program in human colon cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

The mammalian Mediator complex and its role in transcriptional regulation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3672971

Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays

29 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

affy--analysis of Affymetrix GeneChip data at the probe level

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

TopHat: discovering splice junctions with RNA-Seq

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

DEGseq: an R package for identifying differentially expressed genes from RNA-seq data

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

NCBI GEO: archive for functional genomics data sets--10 years on

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

A versatile assay for high-throughput gene expression profiling on universal array matrices

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Bioconductor: open software development for computational biology and bioinformatics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

The Dip Test of Unimodality

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2012.10.035

7 January 2021

10.1016/J.CELL.2012.10.035

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

23178117

1 reference